Azienda USL Toscana Centro — Clinical Trial Site

100 Registered trials

51 Currently recruiting

Organisation

Azienda USL Toscana Centro

Location

Prato, Italy

Identifier

ORG-100014756

Address

Viale Michelangiolo 41, 50125, Italy

Departments

#2654: U.O. Dermatologia II
#4101:SOS Dermatologia Speciale Medica
039017: SOC Oncologia Medica
3206: U.O. Dermatologia II
9215:S.O.C. Dermatologia II
Anestesia e Rianimazione
Associate Professor
Cardiology
Clinica Dermatologica
Clinica Dermatologica Università degli studi di Firenze
Complex Nephrology and Dialysis Facility
COS Medical Oncology
Department of Health Sciences Section of Dermatology
Department of Medical Oncology
Dept. Health Sciences
Dermatologia
Dermatology
Dermatology Department
Dermatology Unit
Dipartimento di Scienze della Salute (DSS
DIPARTIMENTO ONCOLOGIA
Divisione di Oncologia
Medical oncology
Medical Oncology unit
Nephrology
Neurologia 1
Nuovo Ospedale Santo Stefano- Prato, SOC Oncologia medica Santo Stefano
Oncologia
Oncologia Medica
Oncologia Medica Ospedale San Giuseppe
ONCOLOGIO MEDICO
Oncology
Oncology Unit
Osp. S. Giovanni di Dio-Dip. Oncologico ASF, Firenze
Ospedale San Giuseppe, SOC Oncologia Medica Empoli
OU Nephrology and Dialysis
P.O Piero Palagi, Ambulatorio di Immunopatologia
Pediatria
Presidio Ospedaliero Piana di Lucca Dipartimento di Nefrologia
Reparto di Oncologia Medica
S.O.C Medical Oncology
S.O.C. Oncologia Medica
S.O.S. Cardiologia e Elettrofisiologia SMN
Scienze della Salute (DSS)
Sezione di Diabetologia
Skin immunopathology and rare dermatological diseases
SOC Cardiologia Firenze I
SOC Medicina Nucleare
SOC Oncologia Media
SOC Oncologia Medica
SOC Oncologia Medica Santo Stefano / St. Stephen Medical Oncology COS
SOS Dermatologia Speciale Medica
SOS DermatologiaSpeciale Medica
SOS DIABETOLOGIA E MALATTIE METABOLICHE
SOS Ematologia clinica e oncoematologia
SOS Oncoematologia
U.O. Dermatologia I
U.O. DIABETOLOGIA E MALATT. METABOLICHE
Unità di Oncologia Medica
UO Oncologia
UO Oncologia Medica

Clinical trials at this site (100)

Search interface

A multicentre randomised study on percutaneous stellate ganglion block as first-line treatment in patients with electrical storm: the STAR 2… Not authorised

2024-520387-34-00 electrical storm 6
A Phase II, Open-Label, Single Arm, prospective, multicenter study of niraparib plus dostarlimab in patients with pleural mesothelioma posit… Pending

2024-515555-38-01 NON SMALL CELL LUNG CANCER 4
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R… Pending

2024-519818-31-01 Endometrial Cancer Advanced, Recurrent, Metastatic, or 5
Personalized antibiotic TREATment for febrile Urinary Tract Infections in children (TREAT-UTI study): multicenter randomized controlled tria… Pending

2025-520622-38-00 Urinary Tract Infections 5
Prevention of Ribociclib-related hepatotoxicity in breast cancer patients: a phase II, multicentre, open label, single arm trial of Silimari… Pending

2025-521651-22-00 hormone receptor positive, HER2-negative breast cancer 4
A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting

2025-522255-25-00 Fallopian Tube Neoplasms 5 2026-05-18
Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Heart Failure 6 2026-05-08
Zasocitinib in Nonsegmental Vitiligo Recruiting

2025-522309-40-00 Non-segmental vitiligo 4 2026-02-11
A clinical study to assess the efficacy of adjuvant immunotherapy with cemiplimab in patients with surgically removed non-small cell lung ca… Recruiting

2024-519901-36-00 Patients with resected stage II-IIIA non-small cell lun 5 2025-12-17
Phase 2 Study of LAD191 in Adults With Hidradenitis Suppurativa Recruiting

2025-521293-34-00 Moderate-to-severe hidradenitis suppurativa 4 2025-12-09
COLCOT-T2D Recruiting

2024-516646-19-00 Type 2 diabetic patients with no prior cardiovascular ( 5 2025-08-15
Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial Recruiting

2024-516874-31-00 Patients with a low-grade serous epithelial carcinoma o 5 2024-12-10
A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Teno… Recruiting

2023-510422-32-00 Tenosynovial Giant Cell Tumour 5 2024-09-10
Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting

2022-501606-35-01 Platinum-sensitive epithelial ovarian, fallopian tube, 11 2024-02-21
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Small bowel adenocarcinoma 4 2024-02-09
A clinical study of ABSK021 in Patients with Tenosynovial Giant Cell Tumor to determine whether the study drug is safe and how well the ant… Recruiting

2023-503245-58-00 Tenosynovial Giant Cell Tumor 5 2023-10-04
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease Recruiting

2024-516966-12-00 Alzheimer’s disease 4 2026-02-13
A Study to compare RLY-2608 + Fulvestrant with Capivasertib + Fulvestrant in people with PIK3CA-mutated, hormone-receptor positive, HER2-neg… Recruiting

2025-523083-21-00 PIK3CA-mutant Hormone Receptor Positive, Human Epiderma 5 2025-12-08
Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) Recruiting

2024-519261-21-00 Desmoplastic small round cell tumor 4 2025-11-21
Study of Izalontamab Brengitecan (BMS-986507) versus Treatment of Physician’s Choice in Patients with Previously Untreated, Locally Advanced… Recruiting

2024-519871-24-00 Breast cancer 10 2025-11-11
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid… Recruiting

2025-520564-17-00 Hidradenitis suppurativa (HS) 5 2025-10-16